Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example ConditionDefinition/example (Narrative)

Patient Care Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ConditionDefinition.


Generated Narrative: ConditionDefinition

Resource ConditionDefinition "example"

url: http://hl7.org/fhir/ConditionDefinition/example

identifier: id: urn:oid:2.16.840.1.113883.4.642.25.1

name: Hyperlipidemia

title: Hyperlipidemia Status

status: draft

date: 2019-05-26T10:44:00+10:00

description: Hyperlipidemia Status

code: Hyperlipidemia (disorder) (SNOMED CT#55822004)

hasSeverity: false

hasBodySite: false

hasStage: false

definition: https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf

observation

code: Lipid Panel (LOINC#24331-1 "Lipid 1996 panel - Serum or Plasma")

observation

code: Cholesterol (LOINC#35200-5 "Cholesterol [Moles/​volume] in Serum or Plasma")

observation

code: Triglyceride (LOINC#35217-9 "Triglyceride [Moles/​volume] in Serum or Plasma")

observation

code: Cholesterol in HDL (LOINC#2085-9 "HDL Cholesterol")

observation

code: LDL Chol. (Calc) (LOINC#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")

Medications

-Code
*Gemfibrozil (RxNorm#203151)

Plans

-Reference
*http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.